Background Previous systematic reviews have identified a high prevalence of HIV infection
in transgender women in the USA and in those who sell sex (compared with both female …

Introduction HIV‐related stigma and discrimination continue to hamper efforts to prevent new
infections and engage people in HIV treatment, care and support programmes. The …

Background Antiretroviral pre-exposure prophylaxis reduces sexual transmission of HIV. We
assessed whether daily oral use of tenofovir disoproxil fumarate (tenofovir), an antiretroviral …

Background A safe and effective vaccine for the prevention of human immunodeficiency
virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime …

This year marks the thirtieth anniversary of the publication of the study that first reported the
isolation of HIV-1. In this Timeline article, we provide a historical perspective of some of the …

Epidemics of HIV in MSM continue to expand in most low, middle, and upper income
countries in 2013 and rates of new infection have been consistently high among young …

This study examined potential facilitators and barriers to pre-exposure prophylaxis (PrEP)
use and their association with PrEP acceptability and motivations for adherence among 184 …

Background Antiretroviral drugs have been shown to reduce risk of mother‐to‐child
transmission of human immunodeficiency virus (HIV) and are also widely used for post …

Tenofovir (TFV) disoproxil fumarate (TDF)±emtricitabine (FTC) are widely used for HIV
treatment and chemoprophylaxis, but variable adherence may lead to suboptimal …

Objective Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate
(FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and …